T1	Premise 42 267	65-year-old woman referred to the ED for fever and alterations in the CBC: hemoglobin 11.4 g/dL, leukocytes 0.86 x103/μL,(neutrophils 41.9 %, lymphocytes 55.8 %),platelets 48.0 x103/μL, fibrinogen 118 mg/dL,D-dimer 20.2 μg/mL
T2	Premise 269 392	A bone marrow examination was performed and the patient was diagnosed with acute leukemia with t(15;17) in 60% of the cells
T3	Claim 440 549	If asymptomatic, transretinoic acid (ATRA) will be initiated and controls in day hospital will be recommended
T4	Claim 554 632	Treatment with arsenic trioxide, ATRA and supportive therapy will be initiated
T5	Claim 637 781	It is a myeloblastic leukemia type M3, so chemotherapy and heparin treatment will be initiated to control disseminated intravascular coagulation
T6	Claim 786 889	Antibiotic treatment should be started. When the fever disappears, leukemia treatment should be started
T7	Claim 954 991	There is no doubt about the diagnosis
T8	Claim 993 1091	Because if you don't know the translocation, nothing happens... the answers give you the diagnosis
T9	Marker 993 1000	Because
T10	Claim 1093 1172	Now it's time to find out how acute promyelocytic leukemia is currently treated
T11	Disease 1123 1151	acute promyelocytic leukemia
T12	Claim 1174 1211	ATRA aside... which I'm sure you know
T13	Claim 1214 1333	As of 2017, the PETHEMA protocol for APL in low to intermediate risk patients (and/or over 70 years of age) is ATO+ATRA
T14	Claim 1335 1394	In high risk patients, it is treated with ATRA+chemotherapy
R1	Support Ent1:T12 Ent2:T10	
T15	Treatment 1174 1178	ATRA
T16	Treatment 1325 1328	ATO
T17	Treatment 1329 1333	ATRA
T18	Treatment 1377 1381	ATRA
T19	Treatment 1382 1394	chemotherapy
T20	Claim 1631 1656	That is, it is a low risk
T21	Premise 1520 1629	In this case, it doesn't score anything for the score since you have <10,000 leukocytes and >40,000 platelets
T22	Marker 1574 1579	since
R2	Support Ent1:T21 Ent2:T20	
T23	Marker 1631 1638	That is
R3	Attack Ent1:T21 Ent2:T14	
T24	Claim 1658 1674	Correct answer 2
R4	Support Ent1:T24 Ent2:T4	
T25	Treatment 457 482	transretinoic acid (ATRA)
R5	Support Ent1:T13 Ent2:T4	
R6	Attack Ent1:T20 Ent2:T14	
R7	Support Ent1:T20 Ent2:T13	
T26	Claim 1728 1849	One of the main causes of mortality in the induction of a promyelocyte is coagulopathy, but option 3 is totally incorrect
T27	Marker 1816 1819	but
R8	Attack Ent1:T26 Ent2:T5	
T28	Claim 1851 1912	We could only mess things up even more by putting heparin!!!!
R9	Support Ent1:T28 Ent2:T26	
T29	Claim 1913 2108	I don't know what they are explaining right now in the academies, but it is clear that they wanted you to know that many promyelocytes, since 3 little years ago, are not treated with chemotherapy
R10	Attack Ent1:T29 Ent2:T5	
T30	Treatment 569 585	arsenic trioxide
T31	Treatment 587 591	ATRA
T32	Treatment 596 614	supportive therapy
T33	Disease 645 674	myeloblastic leukemia type M3
T34	Treatment 679 691	chemotherapy
T35	Treatment 696 713	heparin treatment
T36	Treatment 786 806	Antibiotic treatment
T37	Treatment 853 871	leukemia treatment
T38	Marker 1979 1982	but
